PharmaVoice Logo

Healthcare Leaders Hub

Sponsored content

Featured promotional

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer

News

Latest stories

PharmaShots

Aug 21, 2026, 12:30 PM

Leads Biolabs Reports NMPA NDA Acceptance for Opamtistomig in Previously Treated Advanced EP-NEC

Shots: Ref: PRNewswire | Image: Leads Biolabs | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post Leads Biolabs Reports NMPA NDA Acceptance for Opamtistomig in Previously Treated Advanced EP-NEC appeared first on PharmaShots.

Express Pharma

Aug 21, 2026, 11:39 AM

Zydus gets final US FDA approval for Ascorbic Acid Injection with 180-Days CGT exclusivity

The product is primarily used for the short-term treatment of scurvy in adult and paediatric patients aged 5 months and older for whom oral administration is not possible, insufficient or contraindicated The post Zydus gets final US FDA approval for Ascorbic Acid Injection with 180-Days CGT exclusivity appeared first on Express Pharma.

PharmaShots

Aug 21, 2026, 11:30 AM

IntraGel Therapeutics and UroGen Pharma Ink Strategic Collaboration &  Investment to Advance TumoCure & Expand Sustained-Release Oncology Pipeline

Shots: Ref: PRNewswire | Image: IntraGel Therapeutics and UroGen Pharma | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect@pharmashots.com The post IntraGel Therapeutics and UroGen Pharma Ink Strategic Collaboration &  Investment to Advance TumoCure & Expand Sustained-Release Oncology Pipeline appeared first on PharmaShots.

Pharma Tech

Aug 21, 2026, 10:59 AM

Roche commits $750m to double Oregon-based US manufacturing capacity

Roche's Oregon fill-finish site will produce both autoinjectors and pre-filled syringes – serving its pipeline and portfolio.

PharmaShots

Aug 21, 2026, 10:30 AM

Rein Therapeutics’ LTI-03 Secures the US FDA Fast Track Designation for Idiopathic Pulmonary Fibrosis

Shots: Ref: Rein Therapeutics | Image: Rein Therapeutics | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect@pharmashots.com The post Rein Therapeutics’ LTI-03 Secures the US FDA Fast Track Designation for Idiopathic Pulmonary Fibrosis appeared first on PharmaShots.

Pharma Tech

Aug 21, 2026, 9:52 AM

Eli Lilly’s weekly insulin jab Onswik set for NHS use if approved

Lilly’s drug could cut the number of injections each patient needs by 85%.

News

Latest industry coverage

Google News

Aug 22, 2026, 12:35 AM

Pharmacy Data into Policy Research… BRP Connect and Pharmaceutical Policy Research Institute Join Hands - 벤처스퀘어

Pharmacy Data into Policy Research… BRP Connect and Pharmaceutical Policy Research Institute Join Hands  벤처스퀘어

Google News

Aug 21, 2026, 11:10 PM

Pharma Co. Loses Challenge To $3M Acne Drug Arb. Award - Law360

Pharma Co. Loses Challenge To $3M Acne Drug Arb. Award  Law360

Google News

Aug 21, 2026, 10:41 PM

Triethyl Citrate Market to Reach 260,000 Tonnes by 2035 as Phthalate Bans Drive Substitution in Food Contact and Medical Devices - IndexBox

Triethyl Citrate Market to Reach 260,000 Tonnes by 2035 as Phthalate Bans Drive Substitution in Food Contact and Medical Devices  IndexBox

Google News

Aug 21, 2026, 9:13 PM

EVERSANA grows AI platform for life sciences - BioXconomy

EVERSANA grows AI platform for life sciences  BioXconomy

Google News

Aug 21, 2026, 7:37 PM

How China’s biotech boom is bringing patients faster, more affordable drugs - BioXconomy

How China’s biotech boom is bringing patients faster, more affordable drugs  BioXconomy

Google News

Aug 21, 2026, 7:28 PM

Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK - Yahoo Finance

Bristol-Myers Squibb (BMY) Bets $2.3 Billion on Texas While Eli Lilly (LLY) Wins in the UK  Yahoo Finance

Google News

Aug 21, 2026, 6:29 PM

Specialty pharmacies: What are they, and how do they affect drug costs? - Healthcare Brew

Specialty pharmacies: What are they, and how do they affect drug costs?  Healthcare Brew

Google News

Aug 21, 2026, 6:15 PM

Alvotech, Lotus Ink Biosimilar Licensing and Commercialization Pact in US, Asia - Contract Pharma

Alvotech, Lotus Ink Biosimilar Licensing and Commercialization Pact in US, Asia  Contract Pharma

Google News

Aug 21, 2026, 5:58 PM

Amplitude Therapeutics Partners with Eli Lilly | PharmExec - Pharmaceutical Executive

Amplitude Therapeutics Partners with Eli Lilly | PharmExec  Pharmaceutical Executive

Sponsored placement

Featured promotions

Jeplus.in
Sponsored

Jeplus.in

Purchase All Medicines.Get 10% Offer